Impact of Heart Transplant Allocation Change on Waitlist Mortality and Posttransplant Mortality in Patients With Left Ventricular Assist Devices
- 1 November 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 17 (11) , e011621
Abstract
BACKGROUND: In October 2018, the US heart transplant (HT) allocation system was revised giving patients with left ventricular assist device (LVAD) intermediate priority status. Few studies have examined the impact of this policy change on outcomes among patients with LVAD. We sought to determine how the allocation change impacted waitlist and posttransplant mortality in patients with LVAD. METHODS: We retrospectively assessed the United Network for Organ Sharing registry for patients with LVAD who were listed for or underwent HT between October 2016 and October 2021. We evaluated waitlist mortality using competing risks analysis and a multivariable Fine-Gray model, and posttransplant mortality using Kaplan-Meier survival analysis and a multivariate proportional hazards model. RESULTS: We analyzed data from 3835 patients with LVAD listed for HT and 3486 patients with LVAD who underwent HT during the study period. Listing for HT preallocation change was significantly associated with an increased risk of waitlist mortality (Gray P =0.0058) compared with postallocation change. After adjustment for covariates, mortality differences by listing era were attenuated, but LVAD brand was significantly associated with waitlist mortality (HM3 versus HMII; hazard ratio, 0.38 [95% CI, 0.21–0.69]; P =0.002; HVAD versus HMII; hazard ratio, 0.79 [95% CI, 0.48–1.30]; P =0.36; overall P =0.004). In contrast, HT postallocation change was associated with increased posttransplant mortality (log-rank P =0.0172) compared with preallocation change. In a multivariable analysis, the association with posttransplant mortality between transplant eras was attenuated, but ischemic time (hazard ratio, 1.16 [95% CI, 1.07–1.26]; P P =0.02) were significantly associated with posttransplant mortality. CONCLUSIONS: Among patients with LVAD, lower waitlist mortality postallocation change was likely driven by improved LVAD technology. Higher posttransplant mortality following the allocation change was largely attributable to longer ischemic times and patient acuity.Keywords
This publication has 32 references indexed in Scilit:
- The Society of Thoracic Surgeons Intermacs 2022 Annual Report: Focus on the 2018 Heart Transplant Allocation SystemThe Annals of Thoracic Surgery, 2022
- Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized TrialJAMA, 2022
- Evolving Trends in Adult Heart Transplant With the 2018 Heart Allocation Policy ChangeJAMA Cardiology, 2021
- Interaction Between Ischemic Time and Donor Age on Adult Heart Transplant Outcomes in the Modern EraThe Annals of Thoracic Surgery, 2019
- First to 50: Early Outcomes Following Heart Transplantation at Royal Papworth Hospital from Donation after Circulatory Determined Death (DCD) DonorsThe Journal of Heart and Lung Transplantation, 2019
- Advanced Heart Failure: A Position Statement of the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure, 2018
- Impact of Left-Ventricular Assist Device–Related Complications on Posttransplant Graft SurvivalThe Annals of Thoracic Surgery, 2017
- The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year updateThe Journal of Heart and Lung Transplantation, 2016
- Impact of Ventricular Assist Device Complications on Posttransplant Survival: An Analysis of the United Network of Organ Sharing DatabaseThe Annals of Thoracic Surgery, 2013
- Characteristics of “Stage D” heart failure: Insights from the Acute Decompensated Heart Failure National Registry Longitudinal Module (ADHERE LM)American Heart Journal, 2008